http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114617857-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88b2da25411502d4b64462b17a418df5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5176
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
filingDate 2022-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8f040f384e2e8c289e0e8f08eea74be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c65edc95a7b8aa0a2818a593f79102ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e41cf242008d132ddbde7722ebd0c2ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9968f2e5ab5badb86be6f155e1508562
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7a25324ca06ab1993864580b1827dd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ee0cfe117d180df83b352328502f87e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d95954be7f8c98fdb7a3940263539651
publicationDate 2022-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114617857-A
titleOfInvention Application and preparation method of bacterial perforating toxin-responsive erythrocyte membrane nanovesicles in broad-spectrum antibacterial
abstract The invention discloses an application of bacterial perforating toxin-responsive erythrocyte membrane nanovesicles in broad-spectrum antibacterial and a preparation method thereof. In the application, the erythrocyte membrane nanovesicles are encapsulated with perfluorooctane to form RBCM@PFC. Before injecting oxygen or nitric oxide. The preparation method has the following steps: 1. obtaining red blood cell membranes; 2. adding red blood cell membranes to perfluorobromooctane and ultrasonically treating them to obtain RBCM@PFC suspension; 3. filling the RBCM@PFC suspension with nitric oxide to obtain RBCM@PFC‑NO Finished product, or add photosensitizing reagent IR780 to RBCM@PFC suspension for ultrasound, and fill with oxygen to obtain RBCM@PFC‑IR780‑O 2 finished product. The invention can realize broad-spectrum antibacterial resistance against drug resistance, overcome the problem that antibiotics are easy to produce drug resistance, and can combine exotoxin neutralization strategy and active gas treatment to achieve effective removal of bacterial infection.
priorityDate 2022-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422601221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559537
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16133648
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426089301
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5488723

Total number of triples: 38.